Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Hans Bishop
Age : 57
Public asset : 68,989,583 USD
Country of residence : Unknown
Linked companies : Agilent Technologies, Inc. - Sana Biotechnology, Inc. - Lyell Immunopharma, Inc.

Biography of Hans Bishop 
Mr. Hans E. Bishop is a Chief Executive Officer & Director at GRAIL, Inc., a Chairman at Sana Biotechnology, Inc., an Independent Director at Agilent Technologies, Inc. and a President & Director at X-Body, Inc. He is on the Board of Directors at GRAIL, Inc., JW (Cayman) Therapeutics Co. Ltd., Agilent Technologies, Inc., JW Biotechnology (Shanghai) Co. Ltd., JW Therapeutics (Shanghai) Co., Ltd., Lyell Immunopharma, Inc. and X-Body, Inc. Mr. Bishop was previously employed as a President, Chief Executive Officer & Director by Juno Therapeutics, Inc., an Independent Director by Avanir Pharmaceuticals, Inc., a Chief Operating Officer by PhotoThera, Inc., an Executive Chairman by Lion Biotechnologies, Inc., a President-Specialty Medicine Business by Bayer HealthCare Pharmaceuticals, Inc., a Senior Vice President-Global Commercial Operations by Chiron Corp., a Chief Operating Officer & Executive Vice President by Dendreon Pharmaceuticals, Inc., a Vice President & General Manager by European Biopharmaceutical Enterprises, a Principal by Glaxo Wellcome Plc, a Principal by GlaxoSmithKline LLC, and an Executive-in-Residence by Warburg Pincus LLC. He also served on the board at Celgene Corp. He received his undergraduate degree from Brunel University.


Current positions of Hans Bishop 
Holdings of Hans Bishop 
Hans Bishop : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
RE
More news


© 2022 People and Ownership :   
Hans Bishop : Connections 


Latest news about Hans Bishop 
2021JW Therapeutics Co. Ltd Announces Board and Committee Changes
CI
2021Illumina, Inc. Announces Executive Changes
CI
2021ILLUMINA : Appoints Bob Ragusa as GRAIL's CEO
MT
2021TRANSCRIPT : Illumina, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-13-2021 02:00 PM
CI
2021TRANSCRIPT : GRAIL, Inc., Illumina, Inc. - M&A Call
CI
2021FTC Seeks to Block Illumina's $7.1 Billion Merger With Life Sciences Firm Grail -- 4th Update
DJ
2021INSIDER TRENDS : Insider at Agilent Technologies Receives Stock Award, Does not Sell, Slowing 90-Day Selling Trend
MT
More news